Colin Hutton
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
-
- Immune cells in cancer
- Toxin Mechanisms and Immunotoxins
Papers in
-
- DNA Repair Mechanisms 1
- Ubiquitin and proteasome pathways 1
- Epigenetics and DNA Methylation 1
- Oncology 5
- PARP inhibition in cancer therapy 2
- Co-authors
- Claus Jørgensen (2 shared papers)Adrián Blanco‐Gómez (2 shared papers)Ian D. Waddell (4 shared papers)James R. Hitchin (4 shared papers)Donald Ogilvie (4 shared papers)Emma Fairweather (3 shared papers)Allan M. Jordan (4 shared papers)Eimear Flanagan (1 shared paper)
- Journals
- Nature Communications (1 paper)Journal of Medicinal Chemistry (1 paper)Cancer Discovery (1 paper)MedChemComm (1 paper)Nature Biotechnology (1 paper)
- Partner nations
- United KingdomAustriaNetherlands
In The Last Decade
Colin Hutton
8 papers receiving 381 citations
Peers
Comparison fields: 5 of 57
- Oncology 202
- Immunology 110
- Physiology 21
- Molecular Biology 175
- Cancer Research 28
Countries citing papers authored by Colin Hutton
This map shows the geographic impact of Colin Hutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Hutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Hutton more than expected).
Fields of papers citing papers by Colin Hutton
This network shows the impact of papers produced by Colin Hutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Hutton. The network helps show where Colin Hutton may publish in the future.
Co-authors
The 25 scholars most cited alongside Colin Hutton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 125 | |
| 2 | 2016 | 97 | |
| 3 | 2021 | 72 | |
| 4 | 2013 | 50 | |
| 5 | 2018 | 27 | |
| 6 | 2023 | 10 | |
| 7 | 2024 | 1 | |
| 8 | 2019 | 1 | |
| 9 | 2025 | 0 |
About Colin Hutton
Colin Hutton is a scholar working on Molecular Biology, Oncology, Immunology, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 383 indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), PARP inhibition in cancer therapy (2 papers), DNA Repair Mechanisms (1 paper), Ferroptosis and cancer prognosis (1 paper), Ubiquitin and proteasome pathways (1 paper), Genetics and Neurodevelopmental Disorders (1 paper), Epigenetics and DNA Methylation (1 paper) and Fluorine in Organic Chemistry (1 paper). The work is most often cited by research in Oncology (202 citations), Immunology (110 citations), Physiology (21 citations), Molecular Biology (175 citations) and Cancer Research (28 citations). Colin Hutton has collaborated with scholars based in United Kingdom, Austria and Netherlands. Frequent co-authors include Claus Jørgensen, Adrián Blanco‐Gómez, Ian D. Waddell, James R. Hitchin, Donald Ogilvie, Emma Fairweather, Allan M. Jordan, Eimear Flanagan, Antonia Banyard and Shih‐Chieh Chiang. Their work appears in journals such as Nature Communications, Journal of Medicinal Chemistry, Cancer Discovery, MedChemComm and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.